What is the Impact Factor of Journal of Psychopharmacology?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Psychopharmacology is 5.30, ranking in quartile Q1 of Web of Science (SCIE).

Is Journal of Psychopharmacology indexed in Web of Science or Scopus?

Yes, Journal of Psychopharmacology is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.683 (Q1) and an H-index of 150.

Who publishes Journal of Psychopharmacology and what is the Article Processing Charge (APC)?

Journal of Psychopharmacology is published by SAGE Publications Ltd. The estimated Article Processing Charge (APC) is approximately $3,532 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Journal of Psychopharmacology?

The official ISO-4 abbreviation of Journal of Psychopharmacology is "J. PSYCHOPHARMACOL". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #1,983Top JournalHybrid

Journal of Psychopharmacology

Abbreviation (ISO):J. PSYCHOPHARMACOL

•

Identifier (ISSN):0269-8811(Print)/1461-7285(Online)

•

Publisher:SAGE Publications Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

5.3↓ -0.2

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Journal of Psychopharmacology

WoS Q1

Annual Impact Factor Metric

Current (2026):5.3

Scopus SJR & RankScopus Q1

1.683

#1,983

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

150

150 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate6.7%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

133articles/year

46.88% Gold OA•78.23% Original Research

Aims & Scope

The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology. The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects. The Journal of Psychopharmacology is truly international in scope and readership.

Topics Covered (Recognized by AI)

Psychology97.5%Medicine97.1%Biology89.1%Psychiatry82.6%Internal medicine76.1%Neuroscience65%Endocrinology53.7%Chemistry53.1%Biochemistry50.6%Pharmacology46.9%Genetics46.3%Receptor39.2%Pathology32%Computer science29.2%Clinical psychology27.1%Anxiety25.9%Cognition24.1%Anesthesia23.1%Programming language23%Schizophrenia (object-oriented programming)20.6%

Primary Research Areas

Rank33/293

IndexSCIE

Category	Index	Rank	Quartile
CLINICAL NEUROLOGY	JCRSCIE	34/296	Q1
NEUROSCIENCES	JCRSCIE	62/330	Q1
PHARMACOLOGY & PHARMACY	JCRSCIE	61/356	Q1
PSYCHIATRY	JCRSCIE	36/293	Q1
CLINICAL NEUROLOGY	JCISCIE	35/296	Q1
NEUROSCIENCES	JCISCIE	40/330	Q1
PHARMACOLOGY & PHARMACY	JCISCIE	31/356	Q1
PSYCHIATRY	JCISCIE	33/293	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF5.3

Articles / Year134

Total Citations68

2025

IF5.5

Articles / Year164

Total Citations477

2024

IF4.5

Articles / Year127

Total Citations1,284

2023

IF4.1

Articles / Year117

Total Citations2,037

2022

IF4.562

Articles / Year138

Total Citations4,030

Year	Impact Factor	Articles / Year	Total Citations
2026	5.3	134	68
2025	5.5	164	477
2024	4.5	127	1,284
2023	4.1	117	2,037
2022	4.562	138	4,030
2021	4.153	138	3,528
2020	3.121	150	4,698
2019	4.221	153	5,956
2018	4.738	143	5,494
2017	—	148	7,180
2016	—	161	11,710
2015	—	136	9,159

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,983Scopus Q1SCImago Profile

Scopus Coverage:1987-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.683

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

5.67

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,532 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,219

3-Year Documents365

Citable Documents340

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate40.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1

PharmacologyQ1

Pharmacology (medical)Q1

Psychiatry and Mental HealthQ1

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 6.7%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区CLINICAL NEUROLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Psychopharmacology (abbr: J. PSYCHOPHARMACOL, ISSN: 0269-8811) is a peer-reviewed international scholarly journal in the field of Medicine, published by SAGE Publications Ltd in England since 1987. The periodical holds a Journal Impact Factor (JIF) of 5.30, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.683 (Q1), an H-index of 150.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 133 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,532 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.